Auckland Breast Cancer Register data is used in a range of research projects.

Here below you will find a list of titles where our data* has been included.
*Personal/service audits and in-house use are excluded.

Year published

Title

Author/s

2018

Outcomes for Patients with Non-metastatic Triple-negative Breast Cancer in New Zealand(external link)

M. James , A. Dixit, B. Robinson , C. Frampton , V. Davey

2017

Poorer survival in males with early breast cancer: Worse prognosis or undertreatment(external link)

D Okonji , D Porter

Contralateral prophylactic mastectomy (CPM) use and utility in New Zealand (NZ) breast cancer patients(external link)

A. Jebb , I. Campbell , R. Shirley , M. Barrios , D. Porter

Body mass index (BMI): association with clinico pathological factors and outcome of women with newly diagnosed breast cancer in New Zealand(external link)

B. Robinson, M. Currie, E. Phillips, G. Dachs, M. Strother, H. Morrin, V. Davey, C. Frampton

2016

Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology(external link)

S. Seneviratne, R. Lawrenson, V. Harvey, R. Ramsaroop, M. Elwood, N. Scott, D. Sarfati and I. Campbell

2015

Patterns of axillary lymph node metastases and recurrent disease in grade 1 breast cancer in a New Zealand cohort: Does ethnicity matter?(external link)

Ineke Meredith, Sanjeewa Seneviratne, Susan Gerreda, Reena Ramsaroop, Richard Harman

2014

Does endocrine therapy in mucinous and tubular breast cancer improve outcomes?(external link)

N Mitchell, D Porter

Trends in Axillary Management of Breast Cancer in Auckland, New Zealand(external link)

P Russell, S Gerred

Contralateral breast cancer (CBC) incidence and risk in New Zealand (NZ)(external link)

A Jebb, I Campbell, R Shirley, M Barrios, D Porter

Contralateral prophylactic mastectomy (CPM) use and utility in New Zealand (NZ) breast cancer patients(external link)

A Jebb, I Campbell, R Shirley, M Barrios, D Porter

2013

Breast Cancer Screening Beyond 70 Years Old(external link)

H Kwok

Patient-reported outcomes following breast reconstruction surgery in a public hospital: use of the Breast-Q questionnaire(external link)

R Cha, E Barnes, M Locke

2012

Can we save the morbidity of Axillary Clearance in Sentinel Node Positive breast cancer patients?(external link)

N Thakore, S Lala, K Hyun, S Gerred

2011

Management of Isolated Tumour Cells, Micrometastases and the Solitary Positive Sentinel Lymph Node in Breast Cancer(external link)

M Puttick, I Cranshaw, W Jones, A Ng

The completeness of cancer treatment data on the national health collections(external link)

J Gurney, D Sarfati, E Dennett, J Koea

Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer(external link)

A Corter, M Findlay, R Broom, D Porter, K Petrie

A Decade of Experience of Intraoperative Analysis of the Sentinel Node in Breast Cancer(external link)

M Puttick, I Cranshaw, W Jones, A Ng

2010

Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index up to 5 Years After Breast Cancer Diagnosis(external link)

V Van Belle, B Van Calster, O Brouckaert, et al.

2007

Differences in breast cancer biological characteristics between ethnic groups in New Zealand(external link)

M Weston, D Moss, J Stewart, A Hill

2005

Systemic Treatment for DCIS(external link)

N McCarthy

How are Auckland Surgeons Managing the Axilla?(external link)

E Whineray Kelly, O Pellett, L Neave, J Harman, R Harman

2003

The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group(external link)

L Neave, V Harvey, C Benjamin, O Pellett, J Whitlock, W Jones, G Poole